Section Arrow
Quote
BRNS.NASDAQ
- Barinthus Biotherapeutics plc
Quotes are at least 15-min delayed:2025/04/13 05:29 EDT
Last
 0.7034
+0.0184 (+2.69%)
Day High 
0.73 
Prev. Close
0.685 
1-M High
1.14 
Volume 
29.81K 
Bid
0.66
Ask
0.8956
Day Low
0.65 
Open
0.73 
1-M Low
0.64 
Market Cap 
27.63M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.78 
20-SMA 0.9 
50-SMA 0.97 
52-W High 3.21 
52-W Low 0.64 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.55/-1.25
Enterprise Value
37.72M
Balance Sheet
Book Value Per Share
3.22
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
14.97M
Operating Revenue Per Share
0.33
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
RXRXRecursion Pharmaceuticals5.76+1.25+27.72%-- 
THTXTheratechnologies1.94+0.61+45.86%-- 
CDTConduit Pharmaceuticals Inc0.9101-0.1599-14.94%-- 
PRTGPortage Biotech Inc8.59+3.49+68.43%0.17PE
HEPAHepion Pharmaceuticals0.422-0.0091-2.11%-- 
Quotes are at least 15-min delayed：2025/04/13 05:29 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.